You are here


 Experts doubt the need to create herd immunity against coronavirus infection.


In order to develop a vaccine against COVID-19, it is necessary to find the key to long-term immune memory when the vaccine is administered. In previous developments, vaccines have only had a short-term effect.


Scientists from the United States conducted a study, during which it turned out that the majority of patients with coronavirus infection develop neurological symptoms.


Previous studies have shown that the contagiousness of SARS-CoV (the causative agent of COVID-19) in mice is less than in humans, can an alternative be found? 


Neurological complications associated with the penetration of the blood-brain barrier of the SARS virus. 


Due to the epidemic situation in the world and a possible second wave of coronavirus infection in winter, the need for vaccination has doubled. 


Another mechanism of action of the antiviral drug remdesivir against SARS-CoV-2 has been discovered. 


What do we know about the transmission modes of COVID-19 today? 


Scientists at the University of Pittsburgh School of Medicine have discovered a super-powerful molecule that has been shown to be "very effective" in preventing and treating COVID-19 when tested in mice and hamsters. 


Why in men, regardless of age, coronavirus infection has a more severe course and worse outcomes, in contrast to women? 


Conducted a multinational, cohort (a type of medical research that is used to identify the causes of disease) study of pregnant women with COVID-19, which answered the question of the effect of the virus on the fetus? 


Myeloid cells play a primary role in innate immunity, namely, they promote the activation and regulation of immune responses, which in the future can be used as preventive therapy in the fight against COVID-19.